TY  - GEN
AU  - Tamminga,Cindy
AU  - Sedegah,Martha
AU  - Maiolatesi,Santina
AU  - Fedders,Charlotte
AU  - Reyes,Sharina
AU  - Reyes,Anatalio
AU  - Vasquez,Carlos
AU  - Alcorta,Yolanda
AU  - Chuang,Ilin
AU  - Spring,Michele
AU  - Kavanaugh,Michael
AU  - Ganeshan,Harini
AU  - Huang,Jun
AU  - Belmonte,Maria
AU  - Abot,Esteban
AU  - Belmonte,Arnel
AU  - Banania,Joglenna
AU  - Farooq,Fouzia
AU  - Murphy,Jittawadee
AU  - Komisar,Jack
AU  - Richie,Nancy O
AU  - Bennett,Jason
AU  - Limbach,Keith
AU  - Patterson,Noelle B
AU  - Bruder,Joseph T
AU  - Shi,Meng
AU  - Miller,Edward
AU  - Dutta,Sheetij
AU  - Diggs,Carter
AU  - Soisson,Lorraine A
AU  - Hollingdale,Michael R
AU  - Epstein,Judith E
AU  - Richie,Thomas L
TI  - Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection
SN  - 2164-554X
PY  - 2014///0825
KW  - Adenoviruses, Human
KW  - genetics
KW  - Adolescent
KW  - Adult
KW  - Antibodies, Protozoan
KW  - blood
KW  - Antigens, Protozoan
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Enzyme-Linked Immunospot Assay
KW  - Female
KW  - Genetic Vectors
KW  - Humans
KW  - Injections, Intramuscular
KW  - Interferon-gamma
KW  - metabolism
KW  - Leukocytes, Mononuclear
KW  - immunology
KW  - Malaria Vaccines
KW  - administration & dosage
KW  - Malaria, Falciparum
KW  - prevention & control
KW  - Male
KW  - Membrane Proteins
KW  - Middle Aged
KW  - Plasmodium falciparum
KW  - Protozoan Proteins
KW  - Vaccines, Synthetic
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.4161/hv.24941
ER  -